Clinical correlation of the CLSI susceptibility breakpoint for piperacillin-tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species - Gavin,P.J.; Suseno,M.T.; Thomson,R.B. (Antimicrob Agents Chemother, 2006)